Search

everythinglearnresearchcommunity

for

Search:↓

Different types of female pattern hair loss have unique characteristics and are associated with various health conditions.

Women with excessive hair growth tend to have shorter index and ring fingers compared to others.

Men face more severe COVID-19 outcomes, while women are more likely to have long-term symptoms.

ALRV5XR effectively promotes hair regrowth in both men and women through different mechanisms.

Men and women with diabetes in Jeddah, Saudi Arabia, experience different symptoms and complications.

The G allele of IFITM3 rs12252 is linked to more severe COVID-19.

South Asian women with PCOS present with different symptoms compared to White women, influenced by ethnicity, obesity, and age.

Females have stronger immune responses to COVID-19 than males, leading to better outcomes.

Finasteride showed limited hair growth and low patient compliance in treating male pattern baldness.

Adjusting AI training data for skin condition distribution improves accuracy across different clinical settings.

Oxymetazoline cream 1.0% effectively reduces rosacea redness, and using baseline photos improves assessment accuracy.

Most men stopped using finasteride for baldness due to unsatisfactory results or were lost to follow-up, and those who continued saw minimal to moderate improvement.

Many women with PCOS have undiagnosed health issues and show different symptoms based on the clinic they visit.

Finasteride 1 mg every other month effectively maintains hair growth in androgenic alopecia.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

Arab hair is generally thicker but less dense compared to other ethnicities, affecting hair disorder diagnosis and treatment.

Treating classic 21-hydroxylase deficiency requires precise glucocorticoid dosing and attention to individual patient needs, with new treatments showing promise.

Hair diameter difference, brown skin discoloration around hair follicles, and missing hair in certain areas are key signs of androgenetic alopecia (commonly known as hair loss) when viewed under a dermoscope.

The document concludes that there is a significant lack of reporting on the sex and age of cells in skin research, which could affect clinical trials and treatments.

Hair restoration surgeons must understand the differences between CTE and FPHL for accurate diagnosis and treatment.

Clinical trials for hair loss in the USA show differences in participation among different races and ethnic groups.

The study developed methods to measure biomarkers in mice and found differences in hormone levels linked to gut microbiota diversity and stress response.

Women with PCOS have distinct clinical and hormonal differences, requiring thorough evaluation for proper diagnosis and management.

R-spondin2 may help treat hair loss, gene differences could explain baldness, a peptide's regulation is linked to psoriasis, B-defensin gene copies may affect a skin condition's risk and severity, and potential markers and targets for alopecia areata were identified.

Understanding sex and gender differences can improve personalized dermatology care.

New treatments for hair growth and psoriasis may be possible, and gene differences could affect baldness and the severity of skin conditions.

The study found that it's hard to tell the difference between two types of hair loss, alopecia areata and telogen effluvium, by looking at symptoms and tissue samples.

The Italian version of a relationship scale was adapted for cancer patients, showing some differences from the original and suggesting its use could improve therapy and treatment adherence.

Different types of polycystic ovary syndrome (PCOS) have varying severity, with Type I being the most severe and common.

Different drug doses approved in Japan and the U.S. are not mainly due to different clinical responses, and ethnic factors should be considered in setting drug doses.